BRIEF

on G&L Healthcare Advisors

Regulatory Expert Appointed to Lead West Coast US Client Engagement for G&L Healthcare Advisors

MADISON, NJ / ACCESSWIRE / June 3, 2024 - G&L Healthcare Advisors has announced the appointment of Richard Edmunds, a veteran with 25 years in regulatory affairs, to lead their U.S. West Coast business expansion from their San Diego office.

Edmunds brings extensive expertise in regulatory and clinical development, partnering with biotech and pharmaceutical clients to expedite drug development and product launches. He has aided over 50 companies in securing regulatory approval.

Richard's expertise combines technical and business acumen, assisting clients from proof-of-concept studies to global expansion and post-approval activities.

Dave Yungvirt, G&L's COO, stated, "We are excited that Richard has agreed to help take G&L to the next level, serving our West Coast clients to ultimately meet patient needs."

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all G&L Healthcare Advisors news